Literature DB >> 17599836

Plasma fibronectin is neuroprotective following traumatic brain injury.

Ciara C Tate1, Andrés J García, Michelle C LaPlaca.   

Abstract

Promotion of repair and regeneration following traumatic brain injury remains a challenging clinical problem. While significant efforts have been made to reduce inhibitory extracellular matrix expression following central nervous system injury, much less attention has been given to the role of endogenous reparative matrix proteins, such as fibronectin. Traumatic brain injury leads to increased levels of plasma-derived fibronectin in the brain tissue, though the specific function of this protein following neurotrauma was unknown. In this study, we utilized conditional plasma fibronectin (pFN) knockout mice to examine the role of fibronectin following a traumatic insult. Injured mice deficient in pFN performed significantly worse on both motor and cognitive tasks, had significantly increased lesion volume and apoptotic cell death, and had significantly less phagocytic cells in the injured cortex compared to injured mice with normal pFN levels. Moreover, intravenous injections of fibronectin prior to the injury restored the neural deficits seen in the pFN deficient mice to that of wild type injured mice. These results demonstrate that fibronectin is neuroprotective to the traumatically injured brain and identify a novel target for therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599836     DOI: 10.1016/j.expneurol.2007.05.008

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  26 in total

1.  Fibronectin EDA forms the chronic fibrotic scar after contusive spinal cord injury.

Authors:  John G Cooper; Su Ji Jeong; Tammy L McGuire; Sripadh Sharma; Wenxia Wang; Swati Bhattacharyya; John Varga; John A Kessler
Journal:  Neurobiol Dis       Date:  2018-04-27       Impact factor: 5.996

Review 2.  Roles of blood-brain barrier integrins and extracellular matrix in stroke.

Authors:  Danielle N Edwards; Gregory J Bix
Journal:  Am J Physiol Cell Physiol       Date:  2018-11-21       Impact factor: 4.249

3.  GALECTIN-8 Is a Neuroprotective Factor in the Brain that Can Be Neutralized by Human Autoantibodies.

Authors:  Evelyn Pardo; Francisca Barake; Juan A Godoy; Claudia Oyanadel; Sofía Espinoza; Claudia Metz; Claudio Retamal; Loreto Massardo; Cheril Tapia-Rojas; Nibaldo C Inestrosa; Andrea Soza; Alfonso González
Journal:  Mol Neurobiol       Date:  2019-05-22       Impact factor: 5.590

4.  Upregulation of fibronectin and the α5β1 and αvβ3 integrins on blood vessels within the cerebral ischemic penumbra.

Authors:  Longxuan Li; Fudong Liu; Jennifer V Welser-Alves; Louise D McCullough; Richard Milner
Journal:  Exp Neurol       Date:  2011-10-28       Impact factor: 5.330

5.  Tumor cohesion and glioblastoma cell dispersal.

Authors:  Ramsey A Foty
Journal:  Future Oncol       Date:  2013-08       Impact factor: 3.404

6.  Fibronectin Matrix Assembly after Spinal Cord Injury.

Authors:  Yunjiao Zhu; Cynthia Soderblom; Michelle Trojanowsky; Do-Hun Lee; Jae K Lee
Journal:  J Neurotrauma       Date:  2015-03-09       Impact factor: 5.269

Review 7.  Role of animal studies in the design of clinical trials.

Authors:  Edward D Hall; Richard J Traystman
Journal:  Front Neurol Neurosci       Date:  2009-03-19

Review 8.  Fibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build.

Authors:  Josephine M J Stoffels; Chao Zhao; Wia Baron
Journal:  Cell Mol Life Sci       Date:  2013-06-12       Impact factor: 9.261

Review 9.  Extracellular matrix and traumatic brain injury.

Authors:  Naijil George; Herbert M Geller
Journal:  J Neurosci Res       Date:  2018-01-18       Impact factor: 4.164

10.  Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury.

Authors:  Philip J Johnson; Stanley R Parker; Shelly E Sakiyama-Elbert
Journal:  J Biomed Mater Res A       Date:  2010-01       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.